Frequency: | |
---|---|
Demographics: | |
Gender; | |
Female | 37 (39.4%) |
Male | 57 (60.6%) |
Deprivation score; | |
1(most deprived) | 5 (5.3%) |
2 | 9 (9.6%) |
3 | 22 (23.4%) |
4 | 27 (28.7%) |
5(least deprived) | 31 (33.0%) |
Six-fold rurality score; | |
Urban | 43 (45.6%) |
Rural | 51 (54.4%) |
Type of recurrence | |
Local | 21 (22.3%) |
Regional | 48 (51.1%) |
Distant | 25 (26.6%) |
Details of first primary: | |
Age at diagnosis; | |
<=50 years | 19 (20.2%) |
51-70 years | 41 (43.6%) |
71+ years | 33 (35.1%) |
Unknown | 1 (1.1%) |
Melanoma type of first primary; | |
Superficial spreading | 27 (28.7%) |
Nodular malignant | 30 (31.9%) |
Lentigo maligna | 5 (5.3%) |
Acral lentiginous | 5 (5.3%) |
Other | 27 (28.7%) |
Location of first primary; | |
Lower limbs | 35 (37.2%) |
Trunk | 20 (21.3%) |
Upper limbs | 9 (9.6%) |
Head and neck | 22 (23.4%) |
Mucus membranes | 4 (4.3%) |
Eye | 4 (4.3%) |
Breslow thickness of first primary; | |
<0.75 mm | 1 (1.1%) |
0.76-4.00 mm | 18 (19.1%) |
>4.00 mm | 36 (38.3%) |
Unknown | 27 (28.7%) |
12 (12.8%) | |
Details of recurrence: | |
Age at recurrence; | |
<=50 years | 14 (14.9%) |
51-70 years | 40 (42.6%) |
71+ years | 40 (42.6%) |
Time to recurrence; | |
0-12 months | 27 (28.7%) |
13-24 months | 28 (29.8%) |
25-36 | 11 (11.7%) |
37-48 | 5 (5.3%) |
49-60 | 7 (7.4%) |
5+ years | 15 (16.0%) |
Unknown | 1 (1.1%) |
How recurrence was detected; | |
Self-detected and reported during interval | 45 (48.9%) |
New finding at follow-up clinical | 30 (31.9%) |
Emergency admission with symptoms in interval | 11 (11.7%) |
Other | 5 (5.3%) |